By Denise Roland | Telegraph
Sativex, a cannabis-derived drug for treating muscle spasms in multiple sclerosis, gets green light in Wales but could still be blocked in England
GW Pharmaceuticals (Stuttgart: A1T980 – news) ‘ cannabis-based multiple sclerosis drug Sativex will be made widely available in Wales, but could still be blocked in England.
The Welsh medicines board on Friday confirmed it had recommended Sativex to relieve muscle spasms in multiple sclerosis, as first reported in the Telegraph earlier this week.
Dr Sajida Javaid, a consultant in rehabilitation medicine at Neath Port Talbot Hospital hailed the Welsh recommendation as a “significant milestone for the treatment of spasticity”.
Sativex was first launched in the UK in 2010, but patients have only been able to access the treatment on an ad hoc basis since, until now, authorities had issued no clear guidance on the use of the drug.
~~~~~~~~~~~~~~~~~~~~
Keep CURRENT and up to date, with MS News and Information
Sign-up for emails
.
WATCH OUR MS EDUCATIONAL VIDEOS by Topic,
found here: www.youtube.com/msviewsandnews
.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
